SDZ-62-434

• Description :

  SDZ-62-434, a platelet-activating factor inhibitor with antitumor activity, inhibits bombesin- and platelet-derived growth factor-induced DNA synthesis in quiescent Swiss 3T3 cells, making it a potential candidate for studying leukemia, human xenograft colorectal cancer, and lung cancer.

• CAS Number :

  115621-95-9

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  416.39

• Molecular Formula :

  C23H27Cl2N3

• Notes :

  Research use only, not for human use.

• Receptor :

  Platelet aggregation